Heart Failure Pathophysiology

Research in heart failure pathophysiology examines the fundamental biological mechanisms that lead to the weakening of the heart muscle and its reduced ability to pump blood effectively. Investigations focus on cellular and molecular processes, including the role of genetic and environmental factors in the development and progression of heart muscle diseases. Studies employ techniques such as molecular biology, cell culture, and animal models to understand how cellular function is disrupted and how these disruptions contribute to the overall decline in cardiac performance. Specific areas of inquiry include the function of non-coding RNAs, the impact of thyroid hormones on cardiovascular health, and the potential for certain drug therapies, like doxorubicin, to cause or be mitigated in heart damage.

This research holds significant public health relevance for Arkansas, a state that faces challenges with cardiovascular disease prevalence. Understanding the underlying causes of heart failure can inform the development of targeted prevention strategies and more effective treatments, potentially reducing healthcare burdens and improving quality of life for Arkansans. By identifying specific molecular pathways involved in heart failure, this work contributes to a broader understanding of cardiovascular health and disease risk factors within the state's population.

This field draws upon expertise across multiple disciplines, including RNA research and splicing, and has connections to cardiovascular function and risk factors. Engagement spans across institutions within Arkansas, fostering collaborative approaches to complex biological questions.